"Red flag" evaluation yield in irritable bowel syndrome

Journal of Gastrointestinal and Liver Diseases

Volumn 21, Issue 2, 2012, Pages 153-156

  Black, Tyler P ^a   Manolakis, Catherine S ^a   Di Palma, Jack A ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

Alarm; Diagnostic testing; Irritable bowel symptoms

Indexed keywords

ADULT; ARTICLE; COLON CANCER; CONSTIPATION; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DIARRHEA; FAMILY HISTORY; FECES INCONTINENCE; FEMALE; FEVER; GASTROINTESTINAL PAIN; HUMAN; IRON DEFICIENCY ANEMIA; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PREVALENCE; RECTUM HEMORRHAGE; SYMPTOMATOLOGY; WEIGHT REDUCTION;

AGE OF ONSET; ANEMIA, IRON-DEFICIENCY; COLONIC DISEASES; CONSTIPATION; DIARRHEA; FEMALE; FEVER; GASTROINTESTINAL HEMORRHAGE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; WEIGHT LOSS;

EID: 84863588804     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Drossman DA, Whitehead WE, Camilleri M. Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology 1997; 112: 2120-2137.
2. Sandler RS. Epidemiology of irritable bowel syndrome in the United States. Gastroenterology 1990; 99: 409-415.
3. Longstreth GF, Wilson A, Knight K, et al. Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspective. Am J Gastroenterology 2003;98: 600-607.
4. Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States. Gastroenterology 2002; 122: 1500-1511.
5. Dean BB, Aguilar D, Barghout V, et al. Impairment in work productivity and health-related quality of life in patients with IBS. Am J Manag Care 2005; 11(1 Suppl):S17-S26.
6. American College of Gastroenterology Task Force on Irritable Bowel Syndrome, Brandt LJ, Chey WD, et al. An evidence based position statement on the management of IBS. Am J Gastroenterology 2009; 104 (Suppl 1): S1-S35.
7. Cash BD, Schoenfeld P, Chey WD. The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review. Am J Gastroenterology 2002; 97: 2812-2819.
8. Mayer EA. Clinical practice. Irritable bowel syndrome. N Engl J Med 2008;358:1692-1699.
9. Hammer J, Eslick GD, Howell SC, Altiparmak E, Talley NJ. Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia. Gut 2004; 53: 666-672.
10. Whitehead WE, Palsson OS, Feld AD, et al. Utility of red flag symptom exclusions in the diagnosis of irritable bowel syndrome. Aliment Pharmacol Ther 2006; 24: 137-146.
11. Cash BD, Chey WD. Diagnosis of Irritable Bowel Syndrome. Gastroenterol Clin North Am 2005; 34: 205-220.
12. Goodman C, Cronin K, Gemmen E, et al. In: The burden of gastrointestinal diseases. Bethesda, MD: American Gastroenterological Association, 2001; 2-65:409-415.
13. Whitehead WE, Drossman DA. Validation of symptom-based diagnostic criteria for irritable bowel syndrome: a critical review. Am J Gastroenterol 2010;105:814-820.
14. Tolliver BA, Herrera JL, DiPalma JA. Evaluation of patients who meet clinical criteria for irritable bowel syndrome. Am J Gastroenterology 1994; 89: 176-178.
15. Chey WD, Nojkov B, Rubenstein JH, Dobhan RR, Greenson JK, Cash BD. The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial. Am J Gastroenterol 2010;105:859-865.
16. Talley NJ, Gabriel SE, Harmsen WS, Zinsmeister AR, Evans RW. Medical costs in community subjects with irritable bowel syndrome. Gastroenterology 1995; 109: 1736-1741.
17. Sanders DS, Carter MJ, Hurlstone DP, et al. Association of adult celiac disease with irritable bowel syndrome: a case-control study in patients fulfilling the ROME II criteria referred to secondary care. Lancet 2001; 358: 1504-1508.
18. Cash BD, Lee D, Riddle M, et al. Yield of diagnostic testing in patients with suspected irritable bowel syndrome (IBS): a prospective, US multicenter trial. Am J Gastroenterology 2008; 103(Suppl 1): S462.
19. Furman DL, Cash BD. The Role of Diagnostic Testing in Irritable Bowel Syndrome. Gastroenterol Clin North Am 2011; 40: 105-119.
20. Ford AC, Chey WD, Talley NJ, Malhotra A, Spiegel BM, Moayyedi P. Yield of diagnostic tests for celiac disease In individuals with symptoms suggestive of irritable bowel syndrome. Arch Intern Med 2009; 169: 651-658.
21. Spiller R, Aziz Q, Creed F, et al. Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut 2007;56:1770-1798.
22. Cash BD, Rubenstein JH, Young PE, et al. The prevalence of celiac disease among patients with nonconstipated irritable bowel syndrome is similar to controls. Gastroenterology 2011;141:1187-1193.
23. Corlew-Roath M, DiPalma JA. Clinical Impact of Identifying Lactose Maldigestion or Fructose Malabsorption in Irritable Bowel Syndrome or Other Conditions. Southern Medical Journal 2009; 102: 1010-12.
24. Pimentel M, Lembo A, Chey WD, et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med 2011;364:22-32.
25. Low K, Hwang L, Hua J, Zhu A, Morales W, Pimentel M. A combination of rifaximin and neomycin is most effective in treating irritable bowel syndrome patients with methane on lactulose breath test. J Clin Gastroenterol 2010;44:547-550.